运动障碍疾病 Movement Disorders

Slides:



Advertisements
Similar presentations
Extrapyramidal disorder and movement disorder
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Evaluation of Movement Disorders
Basal Ganglia module (next slide).
Extrapyramidal diseases. Ⅰ.Formation of basal ganglia *Corpus striatum:/caudate nucleus \ neostriatum \lentiform/putamen nucleus / \lentiform/putamen.
Cortically OriginatedMovement Cortically Originated Movement I. Motor Tract (corticospinal tractus) Extrapyramidal System (basal ganglia) Cerebellum Praxis.
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
An Overview of Conventional and Experimental Treatments
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Idiopathic parkinson’s disease (IPD)
Basal Ganglia: PATHOLOGIES Emma & Amrit. PARKINSON’S HUNTONGTON’S BALISMUS/HEMIBALISMUS ATHETOSIS WILSON’S DISEASE.
Movement part 2. Cerebellum and Brainstem KW p. 363.
Drugs Used to Treat Parkinson’s Disease By Jasmine and Morgan 11/13/03.
EXTRAPYRAMIDAL SYSTEM DISORDERS BASAL GANGLION DYSFUNCTION BASAL GANGLION DYSFUNCTION.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
BASAL GANGLIA PHARMACOLOGY Sammy Case & Matt Vreugde
Parkinson’s Disease By Nik Sanyal.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Basal ganglia & cerebellar pathology
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Some Terminologies White matter : myelinated fibre tracts White matter : myelinated fibre tracts Gray matter : areas of neuronal cell bodies Gray matter.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
1817 by James Parkinson First described in 1817 By English MD James Parkinson Parkinson’s Disease “…involuntary tremulous motion, with lessened muscular.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Making Things Happen - 2 Motor Disorders How Your Brain Works - Week 7 Dr. Jan Schnupp HowYourBrainWorks.net.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
Parkinson’s Disease superKAT :).
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Brainstem and Basal Ganglia
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Imaging Degenerative Diseases of the Brain Cathleen Kouvolo.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Movement Disorders K. Zárubová. Movement disorders MD - abnornal involuntary movements dysfunction of basal ganglia (anatomically) dysfunction of extrapyramidal.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Basal Nuclei Or Basal ganglia By Dr.Musaed Al-Fayez.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Subcortical Motor Systems: Cerebellum & Basal Ganglia Lecture 21.
Extrapyramidal pathway
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Pathogenesis and pathology of parkinsonism
STRUCTURE AND CIRCUITS OF THE BASAL GANGLIA Rastislav Druga Inst. of Anatomy, 2nd Medical Faculty.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Brain Mechanisms of Movement Lecture 19. Hierarchical Control of Movement n Association cortices & Basal Ganglia l strategy : goals & planning l based.
1 EXTRAPYRAMIDAL DISORDERS = Movement disorders = Degenerative disease.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
 DEFINITION: It includes all fibers that can influence the motor end plate activity and do not pass in the pyramidal tract.
Direct motor pathway Corticospinal pathway.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
MOVEMENT DISORDERS ANATOMY The basal ganglia refer to
Parkinson’s Disease.
Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity),
Module 7.3 Movement Disorders
MOVEMENT DISORDERS.
Parkinson's disease KRZYSZTOF NICPOŃ.
EXTRAPYRAMIDAL SYSTEM DISORDERS
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Atypical Parkinsonian Syndromes
Basal ganglia It is a collection of grey matter deeply in each
Neurodegenerative diseases
Presentation transcript:

运动障碍疾病 Movement Disorders Neurology Department The Second Affiliated Hospital Harbin Meical University

Extrapyramidal Disorders General Conception: The dysfunction of basal ganglia putamen globus pallidus lentiform nucleus caudate nucleus subthalamus corpus striatum substantia nigra basal ganglia

General Conception Two types of symptoms Muscular hypotonus associated with hyperkinesia(F1) Muscular hypertonus characterized with hypokinesia(F2)

Parkinson’s disease---conception Also called paralysis agitans. a common degeneration disease in nervous system becomes increasingly common with advancing age characterized by rest tremor, bradykinesia, rigidity, abnormal gait and posture

Parkinson’s disease---Etiology Aging: over middle aged persons Environmental toxin: MPTP(l-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in astrocyte oxidated MPP+ mitochondrion in substantia nigra neuronal death Genetic factor: alpha-synuclein gene -----susceptibility

Parkinson’s disease---Pathology loss of pigmentation and cells in the substantia nigra Lewy body in the basal gangalia, sympathetic ganglia and brainstem.

Parkinson’s disease---Biochemistry L- tyrosine (blood) TH L-Dopa DDC DA MAO and COMT HVA Nigrostriatal pathway is the most important. dopamine depletion dopaminergic nigrostriatal system Extrapyramidal Pathway

dopamine acetylcholine

Parkinson disease’s---Clinical findings Over middle aged & insidious onset and gradual progression. Tremor: often appear as the first sign. Characters: 4~6Hz, conspicuous at rest, increase at times of emotional stress, improves during voluntary activity, stop during sleep, begin from hand , “N” progression.

Parkinson disease’s---Clinical findings Rigidity(F1/F2): lead pipe / cogwheel phenomenon. Minimal rigidity: move the contralateral limb, head dropping test, road mark sign

Parkinson disease’s--Clinical findings Bradykinesia: slowness and reduction of voluntary movement, difficult to initiate, masked face, hypophonia, micrographia. Abnormal gait and posture: flexed posture; difficult to get up, start walking, turn or stop. Shuffling gait and absence of the arm swing. Festinating gait(late sign).

Parkinson disease’s--Clinical findings Other features: Myerson’s sign, oily face, intractable constipation, postural hypotension, cognitive disturbance, hallucination, depression

Parkinson’s disease---Differential diagnosis Parkinsonism: postencephalitic parkinsonism, drug or toxin-induced parkinsonism(CO, Mn), arteriosclerotic parkinsonism. Depression: a trial of antidepressant drug treatment may be helpful.

Parkinson’s disease---Differential diagnosis Essential(benign, familial) tremor: family history, early onset, nod or head shake. Parkinsonism associated with other neurologic diseases: Diffus Lewy body disease(hallucination), Wilson disease, Huntington chorea, multiple system atrophy(MSA), PSP, cortical basal ganglionic degeneration(CBGD).

Parkinson’s disease---Treatment Begin from low dose and individualized. Anticholinergic drugs: helpful in alleviating tremor and rigidity. Artane(1~2mg, tid). Amantadine: for mild parkinsonism. 50mg, bid~tid. Levodopa: L-Dopa/DCI(4:1)---compound; side effects: nausea, hypotension(peripheral) dyskinesia and motor fluction(central) wearing off or on-off phenomenon

Parkinson’s disease---Treatment DA-R agonist: bromocriptine MAOB/COMT inhibitor Surgery: pallidotomy and deep brain stimulation(high frequency thalamic stimulation) Physical therapy and aids for daily living Prognosis dead from complications

Sydenham Chorea--- Conception Also called rheumatic chorea. A usual manifestation of rheumatic fever in nervous system. Presents in childhood or young adult life. Clinical findings involuntary chorea dystonia weakness automatic action disturbance emotional changes

Sydenham Chorea--- Etiology Related with the infection of Hemolytic Streptococcus A. Anti-neuron antibodies can react with the neurons in caudate or subthalamic nucleus. Maybe relate with endocrine changes.

Sydenham Chorea--- Clinical findings 5~15ys. G/B=3:1 Subacute or insidious onset Early symptom: irritability, inattention, unsteady gait, easily dropping objects, et al.

Sydenham Chorea--- Clinical findings Chorea: rapid, irregular, involuntarily, unpredictably obvious on face( facial grimacing and tongue movements) prominent when nervous and disappeared during sleep.

Sydenham Chorea--- Clinical findings Muscle tone and power: reduced. Triad: limb weakness, chorea and ataxia. milkmaid grasp, wax-waning sign, dancing gait. Psychiatric symptom: agitation, hallucination Rheumatic fever findings. Self-limitation

Sydenham Chorea--- Testing 1.Serum test: rapid erythrocyte sedimentation, increased wbc. 2. EEG: unspecific. 3. Image test: 29~85% patients present low density focus in caudate nucleus on CT.

Sydenham Chorea--- Diagnosis&Differential diagnosis Onset age, triad , rheumatic fever findings 1. Habit spasm: stereotyped action on the same muscle 2. Congenital chorea: earlier onset 3. Tourette syndrome: tics on face accompanied by strange voice and dirty words.

Sydenham Chorea--- Diagnosis&Differential diagnosis 4.Huntington Chorea: onset after middle age, dementia, familial history 5. Torsion spasm: continuous, hypermyotonia when torsion happens

Sydenham Chorea--- Treatment & Prognosis rest, keep quiet, avoid stimulation penicillin or other antibiotics(10~14 days) and deltacortone(until the symptoms disapper) apozepam(5mg, bid/tid), haloperidol(0.5~1mg, bid/tid). side effects of extrapyramidal system Self-limited 3~6 months after the onset

Wiloson Disease--- Conception & Etiology Also called hepatolenticular degeneration(HLD) A kind of inherited disease extrapyramidal sign Autosomal recessive cirrhosis inheritance disease psychiatric symptom of copper metabolism kidney impairment disturbance---Etiology K-F circle on cornea

Wiloson Disease--- Clinical findings childhood/young adult life reflect the disproportionate involvement of the caudate nucleus, putamen, cerebral cortex and cerebellum. resting/postural tremor, rigidity, facial grimacing, ataxia, choreiform movements of limbs, disorders of affect , behavior , personality or psychology

Wiloson Disease--- Clinical findings May progress rapaidly(younger); often gradually progress with periods of remission and exacerbation Nonneurologic findings: ocular and hepatic abnormalities

Wiloson Disease--- Differential diagnosis multiple sclerosis juvenile-onset Huntington disease

Wiloson Disease--- Investigative studies Serum copper and ceruloplasmin(CP) are low, and 24h urinary copper excretion is generally increased. Abnormal liver function blood test and aminoaciduria Image test show cerebrocortical atrophy and abnormalities in the basal ganglia.

Wiloson Disease--- Treatment D-Penicillamine(1~1.5g/d): allergic test Restriction of dietary copper zinc sulfate(200mg/d) decrease absorbance Treatment must be continued for life. Early treatment can give a better recovery.